Discover management strategies for alopecia areata, from anti-inflammatory diets to stress reduction techniques that can help ...

Alopecia areata affects 8.3 million people globally, significantly impacting quality of life. PROMs are essential for integrating patient perspectives into drug development and evaluating ...

The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.

Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,000 ...

Corticosteroids can cause cataracts. As they are used to treat alopecia areata (AA) (at least in adults), all patients with AA, including those with single-patch AA, must be examined by an ...

Medical conditions also include alopecia areata which is immune system-related ... drugs such as those used for cancer, arthritis, depression, heart problems, gout and high blood pressure.

Alopecia areata, characterised by patchy bald spots ... Medications: Some drugs used for cancer, arthritis, depression, heart problems, etc., can lead to hair shedding as a side effect of the ...

Masumi Tsunoda, a 45-year-old woman in Maebashi, Gunma Prefecture, who is an alopecia areata patient, was asked to design a headscarf for Licca-chan. Tsunoda contracted the disease 10 years ago.

Q32 Bio, of Waltham, Mass., announced on April 30, 2025 that its human anti-IL-7Rα antibody, bempikibart (ADX-914), has been given fast track designation by FDA for the treatment of alopecia areata ...

April 30, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other ...

has granted Fast Track designation to bempikibart for the treatment of Alopecia Areata (AA), an autoimmune disease that attacks hair follicles causing patchy hair loss. Fast Track is a process ...